Coronary Interventions

Nicolas M Van Mieghem, Kendra J Grubb, David Hildick-Smith, et al

Watch time: 14h 48m 39s (16 videos)

Adrian P Banning, Jonathan Hill, Evald Høj Christiansen, et al

Watch time: 10h 40m 33s (21 videos)

Darren Mylotte, Marie-Claude Morice, Roisin Colleran, et al

Watch time: 28m 31s (3 videos)

Bruno Scheller, Simon Eccleshall, Stefan Tunev, et al

Watch time: 2h 21m 33s (14 videos)
Transcatheter Interventions Online 2022 - On Demand

Joost Daemen, Roxana Mehran, David Hildick-Smith, et al

AI powered CT based Non Invasive CAD testing

Derek Connolly, Claire Norfolk, Sarah Tyers, et al

Watch time: 46m 1s (3 videos)

Joost Daemen, Paolo Canova,

Watch time: 4h 45m 54s (24 videos)
Logo

Gregg Stone, Colin Berry, Adrian P Banning, et al

Watch time: 54m 48s (8 videos)

Jonathan Hill, James Spratt, Charalambos Antoniades, et al

Watch time: 11h 6m 44s (20 videos)

Angela McInerney, Antonio Mangieri, James Spratt, et al

Benjamin Honton , Jacques Monsegu ,

Remo Albiero ,

Media

Joost Daemen, Dagmara Hering,

CardioNerds @AHA23: ORBITA-2: PCI for Stable Angina

Rasha Al-Lamee, Christopher Rajkumar, Nazli Okumus, et al

Watch time: 14m 58s
View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 30m 36s
TCT 23: Four-Year Outcomes from the EVOLUT Low Risk Trial

Michael J Reardon,

Watch time: 8m 46s

Jonathon A Leipsic,

Watch time: 11m 27s (5 videos)
View from the Thoraxcenter: TCT 23 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 25m 48s

James Spratt, Allen Jeremias, Natalia Pinilla, et al

Watch time: 6h 48m 44s (20 videos) (20 videos)

Joost Daemen, Dagmara Hering,

Watch time: 1h 12m 46s

Sean Gallagher, Tom Johnson, Elliot Smith, et al

Watch time: 70m (5 videos)

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
EP 99: ESC 23 Review: Interventional Trials with Dr Mirvat Alasnag

Mirvat Alasnag, Ankur Kalra,

Listen time: 36m 34s
A New Resorbable Magnesium Scaffold for de Novo Coronary Lesions

Michael Haude,

Watch time: 3m 21s

Media

EuroPCR 2024: 5 Trials That Will Change My Practice

Mirvat Alasnag,

Watch time: 4m 13s
View from the Thoraxcenter: EuroPCR 24 Late-breaking Science Wrap Up - Part 1

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 18m 29s

Tomas Kovarnik , Mohamed Ayoub, Giuseppe Di Gioia, et al

Watch time: 14s

Victoria Delgado, Valeria Paradies, Shrilla Banerjee, et al

EuroPCR 24: Influence of Pathophysiological Patterns of CAD on PCI

Carlos Collet,

Watch time: 3m 44s
EuroPCR 24: 5-year Results of the SOLVE-TAVI trial

Hans-Josef Feistritzer,

Watch time: 4m 31s
View from the Thoraxcenter: What's Hot at EuroPCR 24?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 26m 3s

Angela McInerney, Antonio Mangieri, James Spratt, et al

Simon Kennon, Stephan Achenbach, Sergio Baptista, et al

Simon Kennon, Stephan Achenbach, Sergio Baptista, et al

Robert Gerber, Vijay Kunadian, Roby D Rakhit, et al

Image

Bernard J Gersh, Mackram F Eleid,

Watch time: 15m 21s

Articles

Dedicated Bifurcation Stents Strategy

Shao-Liang Chen

,

Imad Sheiban

,

Citation:

Interventional Cardiology 2009;4(1):70-2

DOI:

https://doi.org/10.15420/icr.2009.4.1.70
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 683
  • Downloads: Downloads 8

Effectiveness and Safety of Sirolimus-eluting Stents in Patients with Diabetes

Aleardo Maresta

,

Marco Balducelli

,

Elisabetta Varani

,

Citation:

Interventional Cardiology 2008;3(1):52-4

DOI:

https://doi.org/10.15420/icr.2008.3.1.52
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 400
  • Downloads: Downloads 7

A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease

Albert Schömig

,

Adnan Kastrati

,

Citation:

Interventional Cardiology 2007;2(1):24-6

DOI:

https://doi.org/10.15420/icr.2007.24
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 600
  • Downloads: Downloads 8
  • Citations: 1

Benefit of Drug-eluting Coronary Stents in Reducing In-stent Restenosis

David Holmes Jr

,

Citation:

US Cardiology 2004;1(1):88–90

DOI:

https://doi.org/10.15420/usc.2004.1.1.88
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 516
  • Downloads: Downloads 1